机构:[1]The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.[2]Glaucoma Research Institute, Wenzhou Medical University, Wenzhou, China.[3]National Clinical Research Center for Ocular Diseases, Glaucoma Research Institute of Wenzhou Medical University, The Eye Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, China.[4]Department of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.[5]Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Sha Tin, Hong Kong SAR, China.[6]Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Institute of Ophthalmology, Capital Medical University, No. 1 Dongjiaominxiang Street, Beijing, 100730, Dongcheng District, China.研究所眼科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[7]Beijing Institute of Ophthalmology, Beijing, China.研究所眼科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[8]The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.[9]Glaucoma Research Institute, Wenzhou Medical University, Wenzhou, China.[10]National Clinical Research Center for Ocular Diseases, Glaucoma Research Institute of Wenzhou Medical University, The Eye Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, China.
This study was supported by the Key Research and
Development Projects of Zhejiang Province (2022C03112),
the National Key Research and Development Project of China
(2020YFC2008200), the Program for Zhejiang Leading Talent
of S&T Innovation (2021R52012), the Zhejiang Provincial
Program for the Cultivation of Leading Talents in Colleges
and Universities (2,020,099), and the Foundation for Scientific Research and Development of Wenzhou Medical University
(QTJ13009).
第一作者机构:[1]The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.[2]Glaucoma Research Institute, Wenzhou Medical University, Wenzhou, China.[3]National Clinical Research Center for Ocular Diseases, Glaucoma Research Institute of Wenzhou Medical University, The Eye Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, China.
共同第一作者:
通讯作者:
通讯机构:[6]Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Institute of Ophthalmology, Capital Medical University, No. 1 Dongjiaominxiang Street, Beijing, 100730, Dongcheng District, China.[7]Beijing Institute of Ophthalmology, Beijing, China.[8]The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.[9]Glaucoma Research Institute, Wenzhou Medical University, Wenzhou, China.[10]National Clinical Research Center for Ocular Diseases, Glaucoma Research Institute of Wenzhou Medical University, The Eye Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, China.
推荐引用方式(GB/T 7714):
Zhou Mengtian,Zhu Shuqing,Li Haoyu,et al.Retrocorneal membrane interception enhanced penetrating canaloplasty for patients with open angle glaucoma secondary to ICE syndrome[J].International Ophthalmology.2024,44(1):395.doi:10.1007/s10792-024-03211-9.
APA:
Zhou Mengtian,Zhu Shuqing,Li Haoyu,Ye Wenqing,Xu Shuxia...&Liang Yuanbo.(2024).Retrocorneal membrane interception enhanced penetrating canaloplasty for patients with open angle glaucoma secondary to ICE syndrome.International Ophthalmology,44,(1)
MLA:
Zhou Mengtian,et al."Retrocorneal membrane interception enhanced penetrating canaloplasty for patients with open angle glaucoma secondary to ICE syndrome".International Ophthalmology 44..1(2024):395